The Stability of Peritoneal Dialysis for the Treatment of Chronic Renal Failure in Cirrhotic Patients Acompanying Ascites.
- Author:
Jung In KIM
1
;
Jung Eun LEE
;
Hyun Jeong BAEK
;
Sung Chul CHOI
;
Jung Ho DO
;
Wooseong HUH
;
Yoon Goo KIM
;
Dae Joong KIM
;
Ha Young OH
Author Information
1. Division of Nephrology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea. jungeun34.lee@Samsung.com
- Publication Type:Original Article
- Keywords:
Peritoneal dialysis (PD);
Chronic renal failure (CRF);
Liver cirrhosis;
Ascites
- MeSH:
Anticoagulants;
Ascites*;
Cause of Death;
Fibrosis;
Humans;
Hypoalbuminemia;
Kidney Failure, Chronic*;
Liver Cirrhosis;
Liver Diseases;
Liver Failure;
Peritoneal Dialysis*;
Peritonitis;
Pneumonia;
Renal Replacement Therapy;
Retrospective Studies;
Sepsis
- From:Korean Journal of Nephrology
2007;26(3):334-341
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: When liver cirrhosis patients accompanying ascites need renal replacement therapy because of chronic renal failure (CRF), peritoneal dialysis (PD) can allow direct removal of ascites and prevent anticoagulants use. However, since PD might aggravate hypoalbuminemia and increase chances of peritonitis, clinicians tend to hesitate to apply it to those patients. The aim of the present study is to assess the outcome and stability of PD for the treatment of CRF patient with cirrhosis acompanying ascites. METHODS: A retrospective study based on the clinical records was performed in cirrhotic patients with ascites in whom PD was performed for the treatment of CRF and who were followed up at Samsung Medical Center unit, between January 1995 and July 2005. RESULTS: In our study, 15 patients were enrolled. Child-pugh class was worse in non-survival group than survival group (p<0.01). One-year patient survival was 40% in Class C and 75% in Class B, and patient survival differed between Class C and Class B (p=0.0014). Causes of death were terminal liver failure (n=6) and sepsis due to pneumonia (n=1). Total 27 episodes of peritonitis occurred, and the peritonitis rates were 0.91 episodes/patients-year. CONCLUSION: Although the peritonitis rates turned out somewhat high, the use of PD for the treatment of CRF in patients with liver cirrhosis accompanying ascites seems to be safe and effective. Main cause of death in our study seems to be related to liver disease.
